Hanson & Doremus Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $852K | Sell |
35,388
-22,949
| -39% | -$600K | 0.09% | 108 |
|
|
2026
Q1 | $1.64M | Sell |
58,337
-70,897
| -55% | -$1.89M | 0.19% | 72 |
|
|
2025
Q4 | $3.22M | Sell |
129,234
-5,151
| -4% | -$130K | 0.39% | 41 |
|
|
2025
Q3 | $3.42M | Sell |
134,385
-12,705
| -9% | -$314K | 0.43% | 36 |
|
|
2025
Q2 | $3.56M | Sell |
147,090
-7,299
| -5% | -$170K | 0.48% | 38 |
|
|
2025
Q1 | $3.91M | Buy |
154,389
+15,268
| +11% | +$400K | 0.57% | 33 |
|
|
2024
Q4 | $3.69M | Buy |
139,121
+1,408
| +1% | +$38.2K | 0.58% | 34 |
|
|
2024
Q3 | $3.98M | Sell |
137,713
-452
| -0.3% | -$13.2K | 0.63% | 29 |
|
|
2024
Q2 | $3.87M | Buy |
138,165
+6,265
| +5% | +$172K | 0.65% | 27 |
|
|
2024
Q1 | $3.66M | Buy |
131,900
+15,517
| +13% | +$431K | 0.63% | 30 |
|
|
2023
Q4 | $3.35M | Buy |
116,383
+25,523
| +28% | +$772K | 0.63% | 31 |
|
|
2023
Q3 | $3.01M | Sell |
90,860
-931
| -1% | -$32.9K | 0.62% | 34 |
|
|
2023
Q2 | $3.37M | Sell |
91,791
-1,120
| -1% | -$43.6K | 0.7% | 27 |
|
|
2023
Q1 | $3.79M | Sell |
92,911
-16,767
| -15% | -$724K | 0.84% | 20 |
|
|
2022
Q4 | $5.62M | Buy |
109,678
+11,934
| +12% | +$572K | 1.21% | 14 |
|
|
2022
Q3 | $4.28M | Sell |
97,744
-677
| -0.7% | -$32.9K | 1.11% | 15 |
|
|
2022
Q2 | $5.16M | Sell |
98,421
-3,705
| -4% | -$189K | 1.26% | 11 |
|
|
2022
Q1 | $5.29M | Sell |
102,126
-18
| -0% | -$934 | 1.14% | 15 |
|
|
2021
Q4 | $6.03M | Sell |
102,144
-592
| -0.6% | -$29.3K | 1.29% | 13 |
|
|
2021
Q3 | $4.42M | Sell |
102,736
-10,897
| -10% | -$483K | 1.02% | 15 |
|
|
2021
Q2 | $4.17M | Sell |
113,633
-7,619
| -6% | -$296K | 1.25% | 12 |
|
|
2021
Q1 | $4.39M | Sell |
121,252
-1,240
| -1% | -$44K | 1.02% | 14 |
|
|
2020
Q4 | $4.51M | Buy |
122,492
+2,723
| +2% | +$99.9K | 1.12% | 14 |
|
|
2020
Q3 | $4.17M | Sell |
119,769
-2,125
| -2% | -$74.5K | 1.25% | 12 |
|
|
2020
Q2 | $3.78M | Sell |
121,894
-19,031
| -14% | -$647K | 1.2% | 13 |
|
|
2020
Q1 | $4.36M | Buy |
140,925
+15,451
| +12% | +$526K | 1.48% | 11 |
|
|
2019
Q4 | $4.66M | Buy |
125,474
+2,094
| +2% | +$74.6K | 1.34% | 12 |
|
|
2019
Q3 | $4.21M | Buy |
123,380
+1,287
| +1% | +$46.8K | 1.31% | 14 |
|
|
2019
Q2 | $5.02M | Sell |
122,093
-4,758
| -4% | -$189K | 1.59% | 9 |
|
|
2019
Q1 | $5.11M | Sell |
126,851
-2,224
| -2% | -$89.1K | 1.68% | 10 |
|
|
2018
Q4 | $5.34M | Sell |
129,075
-2,163
| -2% | -$89.8K | 1.93% | 7 |
|
|
2018
Q3 | $5.49M | Sell |
131,238
-1,519
| -1% | -$58.5K | 1.72% | 9 |
|
|
2018
Q2 | $4.57M | Sell |
132,757
-19,551
| -13% | -$668K | 1.5% | 12 |
|
|
2018
Q1 | $5.13M | Buy |
152,308
+13,642
| +10% | +$469K | 1.59% | 11 |
|
|
2017
Q4 | $4.76M | Buy |
138,666
+624
| +0.5% | +$21.3K | 1.59% | 9 |
|
|
2017
Q3 | $4.68M | Buy |
138,042
+4,254
| +3% | +$137K | 1.63% | 8 |
|
|
2017
Q2 | $4.26M | Sell |
133,788
-670
| -0.5% | -$21.1K | 1.58% | 9 |
|
|
2017
Q1 | $4.36M | Sell |
134,458
-3,866
| -3% | -$122K | 1.75% | 10 |
|
|
2016
Q4 | $4.26M | Sell |
138,324
-1,325
| -0.9% | -$40.5K | 1.84% | 10 |
|
|
2016
Q3 | $4.49M | Sell |
139,649
-2,946
| -2% | -$98.5K | 2.08% | 7 |
|
|
2016
Q2 | $4.76M | Sell |
142,595
-975
| -0.7% | -$31.1K | 2.16% | 6 |
|
|
2016
Q1 | $4.04M | Buy |
143,570
+5,420
| +4% | +$155K | 1.83% | 7 |
|
|
2015
Q4 | $4.23M | Buy |
138,150
+2,653
| +2% | +$83.5K | 1.92% | 6 |
|
|
2015
Q3 | $4.04M | Sell |
135,497
-167
| -0.1% | -$5.36K | 1.94% | 6 |
|
|
2015
Q2 | $4.32M | Sell |
135,664
-3,233
| -2% | -$105K | 1.84% | 6 |
|
|
2015
Q1 | $4.58M | Sell |
138,897
-1,365
| -1% | -$43.4K | 1.94% | 7 |
|
|
2014
Q4 | $4.14M | Buy |
140,262
+10,860
| +8% | +$311K | 1.78% | 9 |
|
|
2014
Q3 | $3.63M | Buy |
129,402
+1,486
| +1% | +$41.7K | 1.64% | 11 |
|
|
2014
Q2 | $3.6M | Sell |
127,916
-7,825
| -6% | -$223K | 1.66% | 11 |
|
|
2014
Q1 | $4.14M | Sell |
135,741
-4,274
| -3% | -$127K | 1.95% | 6 |
|
|
2013
Q4 | $4.07M | Sell |
140,015
-12,164
| -8% | -$354K | 1.95% | 7 |
|
|
2013
Q3 | $4.15M | Sell |
152,179
-737
| -0.5% | -$20.1K | 2.1% | 5 |
|
|
2013
Q2 | $4.06M | Buy |
+152,916
| New | +$4.23M | 2.22% | 5 |
|
Other funds holding PFE
Hanson & Doremus Investment Management's PFE Position: Q2 2026 in Review
Hanson & Doremus Investment Management reduced its Pfizer (PFE) stake by 39% in Q2 2026, selling an estimated $600K and leaving 35,388 shares worth $852K. The position accounts for 0.09% of the portfolio, ranked #108.
Hanson & Doremus Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.03M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hanson & Doremus Investment Management held 35,388 shares of Pfizer worth $852K as of Q2 2026.
- Hanson & Doremus Investment Management sold 22,949 Pfizer shares in Q2 2026, an estimated $600K.
- Pfizer made up 0.09% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #108 holding.
- Hanson & Doremus Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Hanson & Doremus Investment Management's Pfizer position peaked at $6.03M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.